Nexus NeroTech Ventures, a brain-health venture capital fund with $200 million in assets, has shut its doors as of March 31.
“Through a recent acquisition, Nexus NeuroTech Ventures has concluded its operations. The firm was founded with a deep commitment to supporting solutions that hold the greatest promise to help people with neurodegenerative, neuropsychiatric and neurodevelopmental conditions,” CEO Jordi Parramon wrote in a post on LinkedIn.
The VC firm, which was backed by Google co-founder Sergey Brin, is in the process of being merged into Brin’s family office, Bayshore Global Management, Bloomberg reported.
data-variant=”card”
data-news-mode=”manual”
>
Read Also:
Blockchain Capital Targets $700 Million For New Funds Despite Broader …
This post was originally published here
